Skip to main content

Clinical Utility of NanoString Gene Fusion Panel to Detect Actionable Gene Fusions/Rearrangements in Fresh and Formalin-fixed Paraffin-embedded Cancer Specimens

From the 2021 Joint Annual Meeting (recorded 6/30/2021)
Presented by Ying Zou, MD, PHD, ABMGG, FACMG

NanoString fusion technology is an innovative multiplexed hybridization method that can interrogate hundreds of gene fusions in a single reaction. This presentation's objective was to determine the performance characteristics and the clinical utility of NanoString fusion assay in a clinical molecular diagnostics laboratory compared to other routine methods.

At the conclusion of this presentation, participants will be able to:

  • Discuss the importance of gene fusions/rearrangements in cancers
  • Assess different methods to detect gene fusions/rearrangement in cancers
  • Outline clinical utility of NanoString in detecting gene fusions/ rearrangements in cancers

ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of General will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

This Intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.